Zhang Z, Yu Y, Asayama K, Hansen T, Maestre G, Staessen J
Hypertension. 2021; 77(3):788-798.
PMID: 33566687
PMC: 7884241.
DOI: 10.1161/HYPERTENSIONAHA.120.12858.
Vaidya A, Mulatero P, Baudrand R, Adler G
Endocr Rev. 2018; 39(6):1057-1088.
PMID: 30124805
PMC: 6260247.
DOI: 10.1210/er.2018-00139.
Baudrand R, Vaidya A
Int J Mol Sci. 2018; 19(2).
PMID: 29439489
PMC: 5855768.
DOI: 10.3390/ijms19020546.
Adlin E, Braitman L, Vasan R
Am J Hypertens. 2013; 26(9):1076-85.
PMID: 23757402
PMC: 3741228.
DOI: 10.1093/ajh/hpt091.
Bloem L, Manatunga A, TEWKSBURY D, Pratt J
J Clin Invest. 1995; 95(3):948-53.
PMID: 7883995
PMC: 441426.
DOI: 10.1172/JCI117803.
Race and hypertension. What is clinically relevant?.
Rutledge D
Drugs. 1994; 47(6):914-32.
PMID: 7521831
DOI: 10.2165/00003495-199447060-00005.
Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.
Weidmann P
Klin Wochenschr. 1980; 58(19):1071-89.
PMID: 7453095
DOI: 10.1007/BF01476878.
[The possibility of stimulation and suppression of renin secretion by sodium deprivation and sodium loading in primary and renal hypertension].
Klaus D, Bocskor A, Fleischer K, Simsch A
Klin Wochenschr. 1970; 48(17):1024-33.
PMID: 5523457
DOI: 10.1007/BF01497207.
Fecal and salivary electrolytes in the diagnosis of primary aldosteronism.
Wilson D, Laidlaw J, RUSE J
Can Med Assoc J. 1971; 105(12):1300-5.
PMID: 5150332
PMC: 1931305.
[Hypermineralocorticoidism and hypertension].
Wolff H, Abdelhamid S
Klin Wochenschr. 1971; 49(6):293-306.
PMID: 4932028
DOI: 10.1007/BF01496448.
[Plasma renin activity in venous renal blood and its stimulation by hydralazine and theophylline (author's transl)].
Klumpp F, Klaus D, Rossler R, Sadowski P
Klin Wochenschr. 1973; 51(17):875-82.
PMID: 4746367
DOI: 10.1007/BF01467740.
Suppressed renin response in unilaterally nephrectomized subjects.
DEILMANN W, Gross F, Lamprecht F, Ziegler M
Klin Wochenschr. 1972; 50(2):112-5.
PMID: 4335526
DOI: 10.1007/BF01484818.
Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.
MBuyamba-Kabangu J, Lepira B, Fagard R, Lijnen P, Ditu M, Tshiani K
Eur J Clin Pharmacol. 1986; 29(5):523-7.
PMID: 2869952
DOI: 10.1007/BF00635887.
Racial differences in antihypertensive therapy: evidence and implications.
Weinberger M
Cardiovasc Drugs Ther. 1990; 4 Suppl 2:379-82.
PMID: 2271400
DOI: 10.1007/BF02603180.
The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
Lucas C, Jenkins P, MENDELS J, Due D, Forbes W, Sirgo M
J Natl Med Assoc. 1991; 83(10):866-71.
PMID: 1800760
PMC: 2571583.
Stimulation of renin secretion by various methods: optional results with hydrochlorothiazide.
Traub Y, Nemes L, ALOOF S, Rosenfeld J
Int Urol Nephrol. 1976; 8(3):247-55.
PMID: 1002400
DOI: 10.1007/BF02082246.
Skin color, ethnicity, and blood pressure II: Detroit whites.
HARBURG E, Gleibermann L, Ozgoren F, Roeper P, Schork M
Am J Public Health. 1978; 68(12):1184-8.
PMID: 736182
PMC: 1654111.
DOI: 10.2105/ajph.68.12.1184.
[Plasma renin activity, plasma volume extracellular fluid volume and cardiac output in essential hypertension (author's transl)].
Haux R, Abholz H, Gotzen R, Schwab M
Klin Wochenschr. 1979; 57(7):319-29.
PMID: 439783
DOI: 10.1007/BF01476562.
Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
Vetter H, Vetter W
Klin Wochenschr. 1975; 53(8):391-3.
PMID: 211313
DOI: 10.1007/BF01468678.
